EGFR and mucinous adenocarcinoma: Liu et al. [27] evaluated the clinical–radiological–pathological characteristics and prognosis of advanced pneumonic-type lung cancer, which predominantly involved diffuse area of lung, and found that the majority of patients had invasive mucinous adenocarcinoma and correlated with the absence of EGFR mutations.